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Edited by Beat ImhofAbstract Glycoprotein 130 (gp130), a common receptor of IL-
6 family cytokines, plays critical roles in cardiac functions. Here,
we demonstrate that the stimulation of gp130 with leukemia
inhibitory factor (LIF) promoted cell adhesion in a cadherin-
dependent manner in cultured cardiomyocytes. Wnt5a was
upregulated by the stimulation of gp130 with IL-6 family
cytokines, accompanied by N-cadherin protein upregulation.
Wnt5a was not induced by LIF in cardiomyocytes expressing
dominant-negative STAT3. Ablation of Wnt5a by antisense
cDNA inhibited LIF-induced cell adhesion. Collectively, signals
through gp130 upregulate Wnt5a through STAT3, promoting
the N-cadherin-mediated cell adhesion.
 2004 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Cardiomyocyte1. Introduction
Glycoprotein 130 (gp130) is a common receptor of inter-
leukin-6 (IL-6) family cytokines. Signals through gp130 are
transduced to signal transducer and activator of transcription
(STAT) [1,2]. In cardiac myocytes, gp130 is activated by some
kinds of IL-6 related cytokines, such as leukemia inhibitory
factor (LIF), cardiotrophin-1 (CT-1), through LIF receptor
[3]. Signals through gp130 regulate the transcription of cyto-
protective genes, including bcl-xL [4], vascular endothelial
growth factor (VEGF) [5], and manganese superoxide dismutase
(MnSOD) [6], through STAT pathway. Thus, it is postulated
that gp130/STAT pathway prevents cardiac myocytes from
myocardial degeneration. Importantly, STAT pathway is ac-
tivated under pathological stresses, such as hypoxia [7], me-
chanical stretch [8] and catecholamine stimulation [9].
Cadherin family proteins are the key regulators in cell ad-
hesion. N-cadherin is abundantly expressed in the heart and
localized at intercalated disks [10]. In cultured cardiomyocytes,
blocking antibody against N-cadherin leads to the disturbance* Corresponding author. Fax: +81-6-6879-8253.
E-mail address: fujio@phs.osaka-u.ac.jp (Y. Fujio).
0014-5793/$22.00  2004 Federation of European Biochemical Societies. Pu
doi:10.1016/j.febslet.2004.07.082of myoﬁbrillogenesis [11]. Pathological analyses demonstrated
that the disruption of the intercalated disks is related with
cardiac disorders, such as dilated cardiomyopathy [12–14],
consistent with the previous report that mice lacking N-cad-
herin show the cardiac abnormality [15]. Thus, it could be
proposed that the cell adhesion through cadherin system is
essential for maintenance of cardiac homeostasis.
Accumulating evidences have demonstrated that Wnt family
proteins modulate cadherin function [16]. Interestingly Wnt3
and Wnt5a can regulate N-cadherin function and promote cell
adhesion in cardiac myocytes [17]. However, biological sig-
niﬁcances of Wnt/cadherin system remain to be fully under-
stood in cardiomyocytes because of limited information about
regulatory mechanisms of Wnt family expression.
Recently, it was reported that loss of function mutation of
STAT pathway in Drosophila shows the impaired motility of
ovarian epithelial cells with the downregulation of D-cadherin
[18]. Here, to address the possibility that gp130/STAT signal-
ing crosstalks with cadherin system, we examined the in-
volvement of gp130/STAT in cell adhesion system in cardiac
myocytes. And it has been demonstrated that the signals
through gp130 upregulate Wnt5a with the induction of N-
cadherin protein and modulate cell–cell interaction.2. Materials and methods
2.1. Cell culture and reagents
Primary cultures of rat neonatal cardiac myocytes were prepared as
described previously [4]. More than 90% of the cultured cells consisted
of cardiac myocytes, analyzed by immunoﬂuorescent microscopy (data
not shown).
In the experiments concerning the signaling pathways downstream
of gp130, wortmannin (Nacalai, Japan) and U0126 (Cell Signaling,
MA) were used. Wortmannin is widely used as an inhibitor for PI3
kinase [19]. U0126 speciﬁcally inhibits MEKs 1 and 2, resulting in the
inhibition of ERKs 1 and 2 (Cell Signaling, MA) [20].
LIF was purchased from Chemicon International (CA). Biological
activity of 50 U/ml is deﬁned as the concentration that induces the dif-
ferentiation of 50% of M1 myeloid leukemic cells, according to the
product protocol.CT-1and IL-6were fromPeprotechEC(London,UK).
2.2. Cell adhesion assay
Cell adhesion was estimated by cell aggregation assay described
previously [21] with minor modiﬁcation. In brief, after stimulated with
various kinds of reagents, cells were washed twice with PBS. Single cellblished by Elsevier B.V. All rights reserved.
Fig. 1. LIF induces cardimyocyte aggregation in a cadherin-dependent
manner. Cardiomyocytes, transduced with adenovirus expressing
dominant-negative N-cadherin (N-CadD) or b-gal, were stimulated
with LIF for 24 h. Single cell suspensions were prepared. Cell aggre-
gation assay was performed as described in Section 2. (A) Represen-
tative phase contrast micrographs were shown (magniﬁcation 40, bar
100 lm). Cardiomyocytes transfected with b-gal show low number of
cell aggregations in the absence of LIF (a), while LIF induces cell
aggregations with more than 100 lm diameter (arrowheads) (b). Note
that dominant-negative N-cadherin inhibited the cell aggregation in-
duced by LIF (c). (B) Cardiomyocyte aggregations were counted in
seven visual ﬁelds. Data were presented as means± standard error.
p < 0:05.
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EGTA and 5 mM EDTA. After centrifuged at 800 rpm for 5 min, cells
were re-suspended in culture medium. Cell suspension (4 105 cells/
ml) was rotated for 1 h and plated on culture dishes at 4 105 cells/cm2
for 30 min. Cell aggregations were counted in number. The myocyte
masses with more than 100 lm diameter were deﬁned to be cell ag-
gregation.
2.3. Adenoviral vectors
Adenoviral vector expressing dominant-negative STAT3 (dnSTAT3)
was constructed as described previously [22].
Dominant-negative N-cadherin cDNA, which encodes truncated N-
cadherin molecule consisting of a large deletion of the extracellular
domain, was gifted by Dr. Jeﬀrey I. Gordon (Washington University)
[23]. Adenovirus vector expressing dominant-negative N-cadherin was
generated as described previously [24]. In brief, dominant-negative N-
cadherin cDNA was subcloned into pCCMVpLpA vector and the
resulting plasmid was co-transfected with pJM17 into 293 cells to allow
for homologous recombination. The adenovirus vector was cloned
from a single plaque and ampliﬁed in 293 cells. The vector was puriﬁed
by ultracentrifugation in the presence of CsCl.
Adenovirus vector expressing sense or antisense Wnt5a cDNA tag-
ged with HA (Upstate, NY) was generated by inserting Wnt5a cDNA
into pCCMVpLpA in sense or antisense direction, followed by the
cotransfection with pJM17 into 293 cells, as described above.
Cardiac myocytes were transduced by the adenovirus vector at MOI
20 as described previously [25]. At this MOI, more than 90% of my-
ocyte population was transduced (data not shown).
2.4. Immunoblot analysis
Cell lysates from cultured cardiac myocytes were generated by
adding 100 ll of SDS sample solution per 35 mm culture dish. Proteins
were separated by SDS–PAGE and transferred onto a polyvinylidene
diﬂuoride membrane. After blocking in TBS-T (150 mMNaCl, 50 mM
Tris, and 0.1% Tween 20, pH 7.4) containing 2% skimmed milk,
membranes were probed with anti-Wnt5a (R&D system, MN), anti-
Cdk4, anti-T-cadherin, anti-HA (Santa Cruz Biotechnology, CA), or
anti-N-cadherin (BD Science, CA) antibody. ECL system (Amersham,
NJ) was used for the detection.
2.5. Northern blot analyses
Northern blot analyses were performed as described previously [5].
The Wnt5a probe was generated by RT-PCR using Reveraace
(TOYOBO, Japan). PCR was performed with primers (forward; GGA
GGT GCC ATG TCT TCC AAG T, reverse; ATG CTC GGC TCA
TGG CGT TCA C). PCR product was subcloned into PCR2.1 vector
(Clontech, CA). EcoRI fragment of the plasmid was used after its se-
quence was conﬁrmed. Total RNA was prepared with the acid guan-
idinium–phenol–chloroform method. Ten micrograms of total RNA
was used for the Northern blotting, as described previously [5].3. Results and discussion
3.1. LIF induces cell aggregation of cultured cardiomyocytes in
a cadherin-dependent manner
To address the biological eﬀects of LIF on cell–cell adhesion,
we examined the cell adhesion activity of LIFby cell aggregation
assay described previously [21]. As shown in Fig. 1, LIF stimu-
lation resulted in cell aggregation in cardiomyocytes transduced
with adenovirus vector expressing b-galactosidase (b-gal), a
control vector, while adenoviral transduction of dominant-
negative N-cadherin inhibited LIF-induced cell aggregation.
3.2. Signals through gp130 upregulate Wnt5a expression
accompanied by N-cadherin induction
In cardiac myocytes, cell–cell adhesion through cadherin
pathway is regulated by Wnt family proteins [17,26]. In the
preliminary assays, we examined the expression of Wnt1, 3, 5a,
8 and 11 in cardiac myocytes by RT-PCR. Wnt1, 3 and 8
mRNAs were not detected in cultured cardiac myocytes.Wnt11 mRNA was detected but its expression was not inﬂu-
enced by LIF, while Wnt5a was expressed in cardiomyocytes
and increased by LIF stimulation (data not shown). Thus, by
Northern blotting analyses, we conﬁrmed that Wnt5a mRNA
was 2.7-fold upregulated in response to LIF (Fig. 2A(a) and
(b)). Importantly, Wnt5a protein was also induced by LIF in
parallel to mRNA (Fig. 2B).
As Wnt5a is reported to stabilize N-cadherin protein [17], we
examined the eﬀects of LIF on the expression of N-cadherin
protein. Cultured cardiac myocytes were stimulated by LIF.
Cell lysates were prepared and immunoblotted with anti-N-
cadherin antibody. As shown in Fig. 3, N-cadherin protein was
upregulated by LIF in a dose-dependent manner, but Cdk4, an
internal control, was not aﬀected by LIF. To rule out the
possibility that LIF upregulates N-cadherin mRNA, we per-
formed Northern blotting for N-cadherin, however, no in-
duction of N-cadherin mRNA was detected (data not shown).
T-cadherin is reported to be expressed in cardiac sarcolemma
[27]. However, the bands with 100 and 120 kDa, corresponding
to T-cadherin, were not aﬀected by LIF stimulation (data not
shown).
3.3. CT-1, but not IL-6, induces Wnt5a and promotes cell
aggregation
To make clear whether or not Wnt5a and N-cadherin are
induced by other signals through gp130, we examined the ef-
fects of IL-6 and CT-1. Cell lysates from cardiomyocytes
stimulated with IL-6 and CT-1 were immunoblotted with anti-
N-cadherin, anti-Wnt5a and anti-Cdk4 antibodies. CT-1 binds
to LIF receptor in cardiomyocytes [3], followed by the re-
markable activation of gp130 signaling pathways, while IL-6
Fig. 3. Stimulation of gp130 by LIF upregulates Wnt5a and N-cad-
herin in cardiac myocytes. Cultured cardiac myocytes were stimulated
with the indicated concentrations of LIF for 24 h. Cell lysates were
prepared and immunoblotted with anti-N-cadherin and anti-Cdk4
antibodies. (A) Representative data are shown. (B) Quantitative
analyses of N-cadherin expression. The band intensity of N-cadherin
was normalized with that of Cdk4. Ratio of N-cadherin expression to
that of control was calculated. Data were presented as means± stan-
dard error. p < 0:05 (n ¼ 3).
Fig. 4. Cardiotrophin-1, but not inteleukin-6, activates Wnt5a/N-
cadherin pathway and promotes cell adhesion. Cardiac myocytes were
stimulated with CT-1 (20 ng/ml), IL-6 (20 ng/ml), or LIF (1000 U/ml)
for 24 h. (A) Cell lysates were prepared and immunoblotted with anti-
N-cadherin, Wnt5a and Cdk4 antibodies. The experiments were re-
peated three times with similar results. (B) Cells were harvested and cell
aggregation assay was performed as described in Section 2. Data were
presented as means± standard error. p < 0:05 versus non-treated cells
(–). NS, not signiﬁcant.
Fig. 2. LIF upregulates Wnt5a mRNA and protein in cultured
cardiomyocytes. Cultured cardiomyocytes were incubated with 1000
U/ml LIF for the indicated time. (A) Total RNA was prepared and
Northern blotted for Wnt5a and GAPDH. (a) Representative data are
shown. (b) Quantitative analyses of Wnt5a mRNA expression. The
band intensity of Wnt5a was normalized with that of GAPDH. Ratio
of Wnt5a expression to control was calculated. Data were presented as
means± standard error. p < 0:05 (n ¼ 3). (B) Cell lysates were im-
munoblotted with anti-Wnt5a and anti-Cdk4 antibodies. The experi-
ments were repeated three times with similar results.
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sion of IL-6 receptor in cardiac myocytes [5]. In parallel,
stimulation of cardiac myocytes with CT-1 upregulated Wnt5a
and N-cadherin, but not that of IL-6 (Fig. 4A). Next, we ex-
amined the eﬀects of CT-1 or IL-6 on cell aggregation. As
shown in Fig. 4B, CT-1 promotes the cell aggregation, but not
IL-6, concomitant with the induction of Wnt5a. These ﬁndings
suggest that gp130-mediated upregulation of Wnt5a is closely
associated with the increase in cell aggregation activity.
3.4. STAT3 is required for LIF-mediated induction of Wnt5a
Next, we analyzed the signaling pathways responsible for
Wnt5a induction using adenovirus vectors expressing
dnSTAT3. Wnt5a mRNA was upregulated by LIF in b-gal-
transfected cell, but not in the cardiomyocytes overexpressing
dnSTAT3 (Fig. 5A), suggesting that STAT3 activity is re-Fig. 5. LIF upregulates Wnt5a expression through STAT3. (A) Cul-
tured cardiomyocytes were transduced with adenovirus vectors ex-
pressing dnSTAT3 or b-gal, as a control, at MOI 20 and cultured with
(+) or without ()) LIF. Total RNA was prepared and Northern
blotted for Wnt5a and GAPDH. (B) Cardiomyocytes, pretreated with
U0126 (2 lM) or wortmannin (200 nM) for 30 min, were stimulated
with 1000 U/ml LIF for 24 h. Total RNA was prepared and Northern
blotted for Wnt5a and for GAPDH.
Scheme 1. Signals through gp130 regulate N-cadherin pathway
through Wnt5a. Activation of gp130 by IL-6 family cytokines, such as
LIF and CT-1, induces Wnt5a through STAT3. Wnt5a promotes cell–
cell adhesion in an N-cadherin dependent manner. Frz; Frizzled Wnt
receptor [17].
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inﬂuences of ERK and PI3 kinase on Wnt5a mRNA induction
in response to LIF by using U0126 and wortmannin, respec-
tively, as described in Section 2. As shown in Fig. 5B, neither
inhibition of ERK nor of PI3 kinase aﬀected the Wnt5a in-
duction by LIF.
3.5. LIF-induced upregulation of Wnt5a contributes to cell
aggregation
To evaluate the importance of Wnt5a in gp130-mediated
cardiomyocyte adhesion, we generated adenovirus vector ex-
pressing sense or antisense Wnt5a mRNA. As shown in
Fig. 6A, N-cadherin was 2.3-fold upregulated by overexpres-
sion of Wnt5a in sense direction, as reported previously [17]. In
contrast, adenoviral gene transfer of antisense Wnt5a cDNA
abrogates LIF-mediated induction of Wnt5a, accompanied by
the downregulation of N-cadherin, but not that of b-gal, a
control. Next, we transduced the adenovirus vectors expressing
sense and antisense Wnt5a, dnSTAT3, and b-gal into the
cardiac myocytes and cell aggregation activity was analyzed
(Fig. 6B). The overexpression of sense Wnt5a promoted cell
adhesion even in the absence of LIF, as reported [17]. LIF did
not promote cell aggregation in cardiomyocytes transfected
with antisense Wnt5a cDNA. Moreover, dnSTAT3 also ab-
rogated LIF-induced cell aggregation. These ﬁndings support
the causality between STAT3-mediated induction of Wnt5a
and cell aggregation.Fig. 6. LIF-mediated induction of Wnt5a is required for cardiomyo-
cyte aggregation. (A) Adenovirus vector expressing sense or antisense
Wnt5a cDNA was generated. Cardiac myocytes were transduced with
adenovirus vector expressing sense (Wnt5a) or antisense (AS-Wnt5a)
Wnt5a cDNA. Adenovirus vector overexpressing b-gal was used as a
control. Twenty-four hours after transduction, cells were treated with
or without 1000 U/ml LIF for 24 h. Cell lysates were prepared and
immunoblotted with anti-N-cadherin, anti-Wnt5a, anti-HA or anti-
Cdk4 antibody. (B) Cells were transduced by adenovirus vectors ex-
pressing b-gal, Wnt5a, AS-Wnt5a, and dnSTAT3. Twenty-four hours
after transduction, cells were treated with or without 1000 U/ml LIF
for 24 h. Cells were collected and cell aggregation assay was performed
as described in Section 2. Data were presented as means± standard
error. p < 0:05.3.6. Signals through gp130 regulate Wnt5a/N-cadherin pathway
In the present study, we have demonstrated that signals
through gp130 upregulated Wnt5a and promoted cardiomyo-
cyte adhesion via N-cadherin pathway. We also revealed that
STAT3 activity is required for Wnt5a induction. Moreover,
ablation of Wnt5a inhibited the upregulation of N-cadherin by
LIF with the abrogation of gp130-mediated cell adhesion,
proposing the functional relation between Wnt5a induction
and cell adhesion through N-cadherin in gp130 signaling
(Scheme 1).
Target disruption of gp130 gene results in myocardial ab-
normality [28], suggesting that gp130 is physiologically in-
volved in cardiac functions. Indeed, it has been demonstrated
that activation of gp130 transduces the cytoprotective signals
[4–6]. Recently, it has been demonstrated that activation of
gp130 by LIF promotes cardiac regeneration after myocardial
infarction [29]. Importantly, the formation of adherens junc-
tion through N-cadherin is a critical step for the cardiac re-
generation from the damage [30]. Collectively, here, we
propose a novel role of gp130 signals as a regulator of cadherin
systems, which might contribute to the maintenance of cardiac
homeostasis, including cardiac repair.
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